This ACI members event will be hosted by ACI experts.
The Advisory Council on the Misuse of Drugs (ACMD) has been commissioned to provide impartial and independent scientific advice on the acceptable levels of constituent cannabinoids in CBD products marketed as consumer products. See ACMD call for evidence on cannabinoids in CBD products.
In this event ACI will gather input from our members for our response.
Date: Monday 12 April 2021
Time: 4pm GMT
This event is exclusively for ACI members.
